Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (26)

2024

  1. Multidisciplinary Delphi consensus on challenges and key factors for an optimal care model in chronic kidney disease

    Nefrologia, Vol. 44, Núm. 5, pp. 678-688

2023

  1. Disease-modifying treatments for patients with multiple sclerosis in Spain

    Farmacia Hospitalaria, Vol. 47, Núm. 4, pp. 155-160

  2. Nutrition in congenital heart disease: Consensus document

    Anales de Pediatria, Vol. 98, Núm. 5, pp. 373-383

  3. Real world data on the demographic and clinicopathological profile and management of patients with early-stage HER2-positive breast cancer and residual disease treated with adjuvant trastuzumab emtansine (KARMA study)

    Cancer Treatment and Research Communications, Vol. 37

2022

  1. Association of rhinitis with asthma prevalence and severity

    Scientific Reports, Vol. 12, Núm. 1

  2. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

  3. Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach

    Future cardiology, Vol. 18, Núm. 9, pp. 743-754

  4. SOLTI-1904 ACROPOLI TRIAL: efficacy of spartalizumab monotherapy across tumor-types expressing high levels of PD1 mRNA

    Future Oncology, Vol. 18, Núm. 34, pp. 3791-3800

2021

  1. Variability of blood eosinophil count and prognosis of COPD exacerbations

    Annals of Medicine, Vol. 53, Núm. 1, pp. 1152-1158

2020

  1. Obesity does not increase the risk of Asthma readmissions

    Journal of Clinical Medicine, Vol. 9, Núm. 1

  2. Severe manifestations of SARS-CoV-2 in children and adolescents: from COVID-19 pneumonia to multisystem inflammatory syndrome: a multicentre study in pediatric intensive care units in Spain

    Critical care (London, England), Vol. 24, Núm. 1, pp. 666

  3. Translation and cross-cultural adaptation into Spanish, Catalan and Galician of the Hopkins Symptom Checklist-25 to identify depression in Primary Care

    Atencion Primaria, Vol. 52, Núm. 8, pp. 539-547

2019

  1. Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations

    International Journal of Clinical Practice, Vol. 73, Núm. 12

  2. Oral metronomic vinorelbine combined with endocrine therapy in hormone receptor-positive HER2-negative breast cancer: SOLTI-1501 VENTANA window of opportunity trial

    Breast Cancer Research, Vol. 21, Núm. 1

  3. Point-of-care ultrasound: Is it time to include it in the paediatric specialist training program?

    Anales de Pediatria, Vol. 91, Núm. 3, pp. 206.e1-206.e13

2018

  1. Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): An open-label, randomized, three-arm, multicenter, window-of-opportunity study

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii64

  2. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis

    The Lancet Neurology, Vol. 17, Núm. 9, pp. 760-772

2017

  1. Asthma exacerbations: factors related to longer hospital stay

    Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine, Vol. 72, Núm. 6, pp. 379-384

  2. Cross-sectional study about impact of parental smoking on rhinitis symptoms in children

    Clinical Otolaryngology, Vol. 42, Núm. 6, pp. 1275-1280

2016

  1. An assessment of the management of spasticity in Spain: The 5E study

    Revista de Neurologia, Vol. 63, Núm. 7, pp. 289-296